Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

Completed · Phase 3

Conditions studied: Iron Deficiency Anaemia, Iron Deficiency Anemia, Chronic Kidney Disease

In brief

Evaluation of safety and efficacy of iron isomaltoside/ferric derisomaltose compared with iron sucrose, in subjects with both non-dialysis-dependent chronic kidney disease (NDD-CKD) and iron deficiency anaemia (IDA).

Key facts

Study ID
NCT02940860
Run by
Pharmacosmos A/S
People needed
1538
Starts
2016-11-29
Expected to finish
2018-05-29
Last updated by the study team
2020-10-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.